Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Construction of a Prognostic Signature in Ewing’s Sarcoma: Based on RNA-binding Genes

View through CrossRef
Abstract Background: Ewing’s sarcoma is the second most prevalent primary malignant bone neoplasm. RNA-binding proteins(RBPs) play a crucial role in post-transcriptional events. In tumor cells, the alterations of post-transcription enable cells to adapt to adjacent environment rapidly. Thus, the functions of RBPs in Ewing’s sarcoma can be of high value in the prognostic[1]. The underlying mechanism between Ewing’s sarcoma and RBPs remained unclear. Methods: Based on the GEO dataset, we investigated the global protein expression profile of Ewing's sarcoma patients. Differentially expressed proteins and survival-related RNA-binding protein related genes (RRGs) were evaluated by computational difference algorithm and COX regression analysis. In addition, we also explored the mutations in these RRGs. A new prognostic indicator based on RRGs was developed and tested afterwards using multivariate COX analysis.Results: The results showed that a total of 16 RRGs which closely associated with the overall survival in Ewing’s sarcoma patients using multivariate Cox regression analysis. The prognosis-related RRGs signature established using Cox regression model consists of 8 RRGs that can divide patients into high-risk and low-risk groups. Our results suggested that overall survival rate of high-risk group patients was shorter than the patients in low-risk group. According to multivariate Cox analysis, risk score index was an independent prognosis factor for Ewing’s sarcoma. In addition, the area under the curve of the corresponding receiver operating characteristic (ROC) curve of survival is 0.947.Conclusion: The 8 RRGs marker can predict the prognosis of Ewing’s sarcoma and thus help individualized treatment of patients at different risks.
Title: Construction of a Prognostic Signature in Ewing’s Sarcoma: Based on RNA-binding Genes
Description:
Abstract Background: Ewing’s sarcoma is the second most prevalent primary malignant bone neoplasm.
RNA-binding proteins(RBPs) play a crucial role in post-transcriptional events.
In tumor cells, the alterations of post-transcription enable cells to adapt to adjacent environment rapidly.
Thus, the functions of RBPs in Ewing’s sarcoma can be of high value in the prognostic[1].
The underlying mechanism between Ewing’s sarcoma and RBPs remained unclear.
Methods: Based on the GEO dataset, we investigated the global protein expression profile of Ewing's sarcoma patients.
Differentially expressed proteins and survival-related RNA-binding protein related genes (RRGs) were evaluated by computational difference algorithm and COX regression analysis.
In addition, we also explored the mutations in these RRGs.
A new prognostic indicator based on RRGs was developed and tested afterwards using multivariate COX analysis.
Results: The results showed that a total of 16 RRGs which closely associated with the overall survival in Ewing’s sarcoma patients using multivariate Cox regression analysis.
The prognosis-related RRGs signature established using Cox regression model consists of 8 RRGs that can divide patients into high-risk and low-risk groups.
Our results suggested that overall survival rate of high-risk group patients was shorter than the patients in low-risk group.
According to multivariate Cox analysis, risk score index was an independent prognosis factor for Ewing’s sarcoma.
In addition, the area under the curve of the corresponding receiver operating characteristic (ROC) curve of survival is 0.
947.
Conclusion: The 8 RRGs marker can predict the prognosis of Ewing’s sarcoma and thus help individualized treatment of patients at different risks.

Related Results

Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Data from Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells
Data from Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells
<div>Abstract<p>Ewing sarcoma is characterized by pathognomonic translocations, most frequently fusing <i>EWSR1</i> with <i>FLI1</i>. An estimat...
Data from Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells
Data from Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells
<div>Abstract<p>Ewing sarcoma is characterized by pathognomonic translocations, most frequently fusing <i>EWSR1</i> with <i>FLI1</i>. An estimat...
Data from BRCA1-Associated RING Domain-1 (BARD1) Loss and GBP1 Expression Enhance Sensitivity to DNA Damage in Ewing Sarcoma
Data from BRCA1-Associated RING Domain-1 (BARD1) Loss and GBP1 Expression Enhance Sensitivity to DNA Damage in Ewing Sarcoma
<div><p>Ewing sarcoma is a fusion oncoprotein–driven primary bone tumor. A subset of patients (∼10%) with Ewing sarcoma are known to harbor germline variants in a growi...
Renal Ewing Sarcoma: A Case Report and Literature Review
Renal Ewing Sarcoma: A Case Report and Literature Review
Abstract Introduction Primary renal Ewing sarcoma is an extremely rare and aggressive tumor, representing less than 1% of all renal tumors. This case report contributes valuable in...
Abstract 4401: Implications of STAG2 loss in Ewing sarcoma
Abstract 4401: Implications of STAG2 loss in Ewing sarcoma
Abstract Ewing sarcoma is an aggressive pediatric bone and soft tissue cancer that is driven by a translocation event, predominantly involving the RNA binding pro...

Back to Top